Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus
Open accessThe DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Glycemic control is important in diabetes mellitus to minimize the progression of the disease and the risk of potentially devastating complications. Inhibition of the sodium-glucose cotransporter SGLT2 induces glucosuria and has been established as a new anti-hyperglycemic strategy. SGLT1 plays a distinct and complementing role to SGLT2 in glucose homeostasis and, therefore, SGLT1 inhibition may also have therapeutic potential. AREAS COVERED: This review focuses on the physiology of SGLT1 in the small intestine and kidney and its pathophysiological role in diabetes. The therapeutic potential of SGLT1 inhibition, alone as well as in combination with SGLT2 inhibition, for anti-hyperglycemic therapy are discussed. Additionally, this review considers the effects on other SGLT1-expressing organs like the heart. EXPERT OPINION: SGLT1 inhibition improves glucose homeostasis by reducing dietary glucose absorption in the intestine and by increasing the release of gastrointestinal incretins like glucagon-like peptide-1. SGLT1 inhibition has a small glucosuric effect in the normal kidney and this effect is increased in diabetes and during inhibition of SGLT2, which deliver more glucose to SGLT1 in late proximal tubule. In short-term studies, inhibition of SGLT1 and combined SGLT1/SGLT2 inhibition appeared to be safe. More data is needed on long-term safety and cardiovascular consequences of SGLT1 inhibition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Genome-wide atlas of gene expression in the adult mouse brain
Lein, E. S., Hawrylycz, M. J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A. F., Boguski, M. S., Brockway, K. S., Byrnes, E. J., et al. (2007) · Nature · doi:10.1038/nature05453 · Cited by 5,572
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339 · cited 1×
“in the setting of hyperglycemia.[132] Multiple studies in diabetic rodents, including genetic models of T1DM and”
BackgroundTolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F., & Gribble, F. M. (2012) · Diabetes · doi:10.2337/db11-1019 · Cited by 2,404
Nasir, O. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000350152 · Cited by 2,331
Diabetic Cardiomyopathy Revisited
Boudina, S., & Abel, E. D. (2007) · Circulation · doi:10.1161/circulationaha.106.679597 · Cited by 1,543 · cited 3×
“[144] In STZ-induced T1DM rats, GLUT4 mRNA and protein expression as well as glucose uptake in the heart were decreased, and restored by insulin administration, whereas GLUT1 mRNA expression was not significantly altered.[142,145] Contractile dysfunction was evident in the hearts of T2DM db/db mice; this was associate…”
BackgroundBiology of Human Sodium Glucose Transporters
Wright, E. M., Loo, D. D. F., & Hirayama, B. A. (2011) · Physiological Reviews · doi:10.1152/physrev.00055.2009 · Cited by 1,430 · cited 10×
“[125] Glucose is transported across the apical membrane of the proximal tubule by SGLT2 and SGLT1 and then exits through the basolateral membrane by the facilitative GLUTs – GLUT2 and GLUT1.”
BackgroundInfluentialThe SLC2 (GLUT) family of membrane transporters
Mueckler, M., & Thorens, B. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.07.001 · Cited by 1,328 · cited 1×
“and insulin-stimulated glucose uptake into skeletal muscle.[3,4] The SGLT transporters belong to the SLC5 gene family, which currently includes six members containing transporters and a channel that vary in their preferences for sugar binding.”
BackgroundExpression cloning and cDNA sequencing of the Na+/glucose co-transporter
Hediger, M. A., Coady, M. J., Ikeda, T. S., & Wright, E. M. (1987) · Nature · doi:10.1038/330379a0 · Cited by 1,004 · cited 3×
“[19,20] In 1987, Wright and co-workers cloned SGLT1 from rabbit.[21] Human SGLT1, encoded by the SLC5A1 gene on chromosome 22q13.”
BackgroundMethodEhrenkranz, J. R. L., Lewis, N. G., Ronald Kahn, C., & Roth, J. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.532 · Cited by 930 · cited 3×
“selective SGLT2 inhibitors.[158] Canagliflozin is an approved SGLT2 inhibitor that also is a low-potency SGLT1 inhibitor (IC50 ratio of 155:1).”
BackgroundT1R3 and gustducin in gut sense sugars to regulate expression of Na + -glucose cotransporter 1
Margolskee, R. F., Dyer, J., Kokrashvili, Z., Salmon, K. S. H., Ilegems, E., Daly, K., Maillet, E. L., Ninomiya, Y., Mosinger, B., & Shirazi-Beechey, S. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706678104 · Cited by 882 · cited 1×
“[79,80,82] The sweet taste receptor subunit T1R3 and the taste G protein gustducin, expressed in enteroendocrine L-cells, are involved in intestinal sensing of dietary sugar and artificial sweeteners which subsequently upregulates intestinal SGLT1 mRNA and protein expression.[83,84] Short-term upre-”
BackgroundSgk1-Dependent Stimulation of Cardiac Na+/H+Exchanger Nhe1 by Dexamethasone
Voelkl, J., Pasham, V., Ahmed, M. S. E., Walker, B., Szteyn, K., Kuhl, D., Metzler, B., Alesutan, I., & Lang, F. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350120 · Cited by 857
Rossetti, L., Smith, D., Shulman, G. I., Papachristou, D., & DeFronzo, R. A. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112981 · Cited by 809 · cited 1×
“[169] Recent studies using selective SGLT2 inhibition and mice lacking SGLT1 defined more precisely the renal transport”
Background(Patho)physiological Significance of the Serum- and Glucocorticoid-Inducible Kinase Isoforms
Lang, F., Böhmer, C., Palmada, M., Seebohm, G., Strutz-Seebohm, N., & Vallon, V. (2006) · Physiological Reviews · doi:10.1152/physrev.00050.2005 · Cited by 689 · cited 1×
“in the diabetic kidney in rodents and humans.[138,139] Studies in T1DM Akita mice lacking SGK1 indicated that the kinase may stimulate electrogenic glucose transport in”
BackgroundSelf-citationGorboulev, V., Schürmann, A., Vallon, V., Kipp, H., Jaschke, A., Klessen, D., Friedrich, A., Scherneck, S., Rieg, T., Cunard, R., et al. (2012) · Diabetes · doi:10.2337/db11-1029 · Cited by 687
Self-citationBonner, C., Kerr-Conte, J., Gmyr, V., Queniat, G., Moerman, E., Thévenet, J., Beaucamps, C., Delalleau, N., Popescu, I., Malaisse, W. J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3828 · Cited by 670 · cited 4×
“human parotid and submandibular salivary glands, liver, lung, skeletal muscle, heart, and pancreatic alpha cells.[21,27,40,55]”
BackgroundMethodInfluentialActive sugar transport in health and disease
Wright, E. M., Hirayama, B. A., & Loo, D. F. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01746.x · Cited by 627 · cited 2×
“and insulin-stimulated glucose uptake into skeletal muscle.[3,4] The SGLT transporters belong to the SLC5 gene family, which currently includes six members containing transporters and a channel that vary in their preferences for sugar binding.”
BackgroundSGLT2 Mediates Glucose Reabsorption in the Early Proximal Tubule
Vallon, V., Platt, K. A., Cunard, R., Schroth, J., Whaley, J., Thomson, S. C., Koepsell, H., & Rieg, T. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010030246 · Cited by 563 · cited 4×
“[37] This response mimicked the reduced renal SGLT1 protein expression observed in response to Sglt2 gene knockout in mice [17] and in response to phar-”
BackgroundInfluentialSelf-citationScheen, A. J. (2015) · Drugs · doi:10.1007/s40265-014-0337-y · Cited by 554
O’Keefe, J. H., & Bell, D. S. H. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.107 · Cited by 538 · cited 1×
“[164,165] As discussed earlier, glucose absorption from the”
BackgroundSugar Absorption in the Intestine: The Role of GLUT2
Kellett, G. L., Brot-Laroche, E., Mace, O. J., & Leturque, A. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155518 · Cited by 492
Vallon, V., Gerasimova, M., Rose, M. A., Masuda, T., Satriano, J., Mayoux, E., Koepsell, H., Thomson, S. C., & Rieg, T. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00520.2013 · Cited by 483 · cited 7×
“[17,37] As discussed earlier, SGLT2 and SGLT1 can account for all renal glucose reabsorption in normoglycemic mice.”
BackgroundMethodInfluentialSelf-citationSpector, K. S. (1998) · Clinical Cardiology · doi:10.1002/clc.4960211205 · Cited by 443 · cited 1×
“[143] The involved pathophysiology remains poorly understood.”
Molecular physiology of sodium-glucose cotransporters.
Hediger, M. A., & Rhoads, D. B. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.4.993 · Cited by 417 · cited 1×
“5 of 2–5 mM for glucose), and transport occurs with a 1:1 stoichiometry.[5,24,25]”
BackgroundThe Role of SGLT1 and GLUT2 in Intestinal Glucose Transport and Sensing
Röder, P. V., Geillinger, K. E., Zietek, T. S., Thorens, B., Koepsell, H., & Daniel, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089977 · Cited by 408 · cited 1×
“[15,63,73,74] In addition, alpha-gustducin-coupled T1R3”
Self-citationAltered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice
Belke, D. D., Larsen, T. S., Gibbs, E. M., & Severson, D. L. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.5.e1104 · Cited by 401 · cited 3×
“[142,145] Contractile dysfunction was evident in the hearts of T2DM db/db mice; this was associated with a 52% and 84% reduction in the rate of glycolysis and glucose oxidation, respectively, whereas palmitate oxidation was increased twofold in db/db hearts versus controls.[146] Both glucose metabolism and palmitate m…”
BackgroundInfluentialSGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials
Inzucchi, S. E., Zinman, B., Wanner, C., Ferrari, R., Fitchett, D., Hantel, S., Espadero, R.-M., Woerle, H.-J., Broedl, U. C., & Johansen, O. E. (2015) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114559852 · Cited by 399
Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences
Gallo, L. A., Wright, E. M., & Vallon, V. (2015) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114561992 · Cited by 395 · cited 2×
“[5,7,8] Diabetes increases the renal SGLT2 expression and the glucose transport maximum (from ~500 g/day to 600 g/day), thereby further enhancing renal glucose reabsorption.[5,7,8] SGLT2 inhibitors improve glycemic control by increasing urinary glucose excretion as shown in experimental models and patients with hyperg…”
BackgroundSelf-citationGribble, F. M., Williams, L., Simpson, A. K., & Reimann, F. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1147 · Cited by 393 · cited 1×
“in a metabolism-independent way.[174] A recent study in”
ResultGlucose/galactose malabsorption caused by a defect in the Na+/glucose cotransporter
Turk, E., Zabel, B., Mundlos, S., Dyer, J., & Wright, E. M. (1991) · Nature · doi:10.1038/350354a0 · Cited by 383 · cited 2×
“[66,67] The phenotype includes neonatal onset of osmotic diarrhea caused by the non-absorbed excess of glucose and galactose in the intestinal lumen, leading to dehydration, metabolic acidosis, and death.”
BackgroundVallon, V., & Thomson, S. C. (2012) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020911-153333 · Cited by 376 · cited 2×
“diabetes.[7,133] In comparison, the reported data for SGLT1 appear more variable with evidence for increased, unchanged, or reduced renal SGLT1 expression in diabetes”
ResultSelf-citationAbel, E. D., Kaulbach, H. C., Tian, R., Hopkins, J. C. A., Duffy, J., Doetschman, T., Minnemann, T., Boers, M.-E., Hadro, E., Oberste-Berghaus, C., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7605 · Cited by 358 · cited 1×
“In the absence of diabetes, cardiac-specific inactivation of GLUT4 abolished insulin-stimulated glucose uptake, but increased cardiac GLUT1 expression and basal glucose transport by threefold; this was associated with modest cardiac hypertrophy and compensated contractile performance.[144] In STZ-induced T1DM rats, GL…”
BackgroundDapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects
Komoroski, B., Vachharajani, N., Boulton, D., Kornhauser, D., Geraldes, M., Li, L., & Pfister, M. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.251 · Cited by 350
The Mechanisms and Therapeutic Potential of SGLT2 Inhibitors in Diabetes Mellitus
Vallon, V. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-051013-110046 · Cited by 348 · cited 4×
“diabetes.[7,133] In comparison, the reported data for SGLT1 appear more variable with evidence for increased, unchanged, or reduced renal SGLT1 expression in diabetes”
BackgroundResultInfluentialSelf-citationLiao, R., Jain, M., Cui, L., D’Agostino, J., Aiello, F., Luptak, I., Ngoy, S., Mortensen, R. M., & Tian, R. (2002) · Circulation · doi:10.1161/01.cir.0000034049.61181.f3 · Cited by 333
Expression of monosaccharide transporters in intestine of diabetic humans
Dyer, J., Wood, I. S., Palejwala, A., Ellis, A., & Shirazi-Beechey, S. P. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00310.2001 · Cited by 320 · cited 4×
“Human Small intestine RT-PCR [116]/up Western Blotting [116]/up Heart RT-PCR [35]/up Mouse Duodenum RT-PCR [114]/up Kidney RT-PCR [38]/down Western blotting [38]/up; [37]/down Rat Small intestine RT-PCR [62]/up Kidney RT-PCR [118,119]/up Western blotting [120]/up; [121–123]/ unchanged Brain (ventromedial hypothalamus)…”
BackgroundMethodInfluentialRieg, T., Masuda, T., Gerasimova, M., Mayoux, E., Platt, K., Powell, D. R., Thomson, S. C., Koepsell, H., & Vallon, V. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00518.2013 · Cited by 310 · cited 15×
“[17,37] As discussed earlier, SGLT2 and SGLT1 can account for all renal glucose reabsorption in normoglycemic mice.”
BackgroundInfluentialSelf-citationQuantitative PCR tissue expression profiling of the human SGLT2 gene and related family members
Chen, J., Williams, S., Ho, S., Loraine, H., Hagan, D., Whaley, J. M., & Feder, J. N. (2010) · Diabetes Therapy · doi:10.1007/s13300-010-0006-4 · Cited by 307 · cited 5×
“It is worth noting that brain expression of SGLT1 has been proposed in other species, such as rats, mice, and pigs, using in situ hybridization and immunological and RT-PCR techniques.”
BackgroundMethodInfluentialJoshi, S. R., Standl, E., Tong, N., Shah, P., Kalra, S., & Rathod, R. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1070827 · Cited by 303 · cited 2×
“[172] Notably, treatment with AGIs, acarbose in particular, was reported to have beneficial effects on lipid levels, blood pressure, carotid intima-media thickness and endothelial dysfunction as well as incretin hormones and the gut-microbiota.[172] In contrast to SGLT1 inhibition, AGIs do not alter the intestinal abs…”
BackgroundSha, S., Devineni, D., Ghosh, A., Polidori, D., Chien, S., Wexler, D., Shalayda, K., Demarest, K., & Rothenberg, P. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01406.x · Cited by 297
Vrhovac, I., Balen Eror, D., Klessen, D., Burger, C., Breljak, D., Kraus, O., Radović, N., Jadrijević, S., Aleksic, I., Walles, T., et al. (2015) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1619-7 · Cited by 290 · cited 6×
“It is worth noting that brain expression of SGLT1 has been proposed in other species, such as rats, mice, and pigs, using in situ hybridization and immunological and RT-PCR techniques.”
BackgroundMethodInfluentialSelf-citationMartín, M. G., Turk, E., Lostao, M. P., Kerner, C., & Wright, E. M. (1996) · Nature Genetics · doi:10.1038/ng0296-216 · Cited by 278 · cited 2×
“[66,67] The phenotype includes neonatal onset of osmotic diarrhea caused by the non-absorbed excess of glucose and galactose in the intestinal lumen, leading to dehydration, metabolic acidosis, and death.”
BackgroundHeise, T., Seewaldt‐Becker, E., Macha, S., Hantel, S., Pinnetti, S., Seman, L., & Woerle, H. J. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12073 · Cited by 273
Incretin Action in the Pancreas: Potential Promise, Possible Perils, and Pathological Pitfalls
Drucker, D. J. (2013) · Diabetes · doi:10.2337/db13-0822 · Cited by 272 · cited 1×
“these effects contribute to the anti-hyperglycemic effect of GLP-1 receptor agonist, which are used as antidiabetic drugs.[72] Oral administration of glucose to mice induced”
BackgroundRegulation of intestinal sugar transport
Ferraris, R. P., & Diamond, J. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.1.257 · Cited by 271 · cited 1×
“[79,80,82] The sweet taste receptor subunit T1R3 and the taste G protein gustducin, expressed in enteroendocrine L-cells, are involved in intestinal sensing of dietary sugar and artificial sweeteners which subsequently upregulates intestinal SGLT1 mRNA and protein expression.”
BackgroundGlucose transport by human renal Na + / d -glucose cotransporters SGLT1 and SGLT2
Hummel, C. S., Lu, C., Loo, D. D. F., Hirayama, B. A., Voss, A. A., & Wright, E. M. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00388.2010 · Cited by 270 · cited 2×
“[15–18] Whereas SGLT2 transports sodium and glucose in a 1:1 ratio, two sodium ions accompany one glucose molecule when transported through SGLT1, which enhances the concentrating power to reabsorb the small amounts of glucose delivered to the late proximal tubule.[25] Both cotransporters are electrogenic and luminal…”
BackgroundLee, W. S., Kanai, Y., Wells, R. G., & Hediger, M. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32677-7 · Cited by 268
Polidori, D., Sha, S., Mudaliar, S., Ciaraldi, T. P., Ghosh, A., Vaccaro, N., Farrell, K., Rothenberg, P., & Henry, R. R. (2013) · Diabetes Care · doi:10.2337/dc12-2391 · Cited by 261 · cited 1×
“[158] Oral application of canagliflozin likewise delayed the appearance of oral glucose in plasma thereby reducing postprandial plasma glucose and insulin levels in healthy subjects.[167] The inhibition of intestinal glucose uptake has also been shown by selective SGLT1 inhibition using KGA-2727 in rats and GSK1614235…”
Zambrowicz, B., Freiman, J., Brown, P. M., Frazier, K. S., Turnage, A., Bronner, J., Ruff, D., Shadoan, M., Banks, P., Mseeh, F., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.58 · Cited by 243 · cited 6×
“[68,69,74,76] It has been proposed that bacterial fermentation of luminal glucose to short-chain-fatty-acids (SCFAs), which”
BackgroundInfluentialDeranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy
Lang, F., Klingel, K., Wagner, C. A., Stegen, C., Wärntges, S., Friedrich, B., Lanzendörfer, M., Melzig, J., Moschen, I., Steuer, S., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.8157 · Cited by 227 · cited 9×
“[138,139] Studies in T1DM Akita mice lacking SGK1 indicated that the kinase may stimulate electrogenic glucose transport in the diabetic proximal tubule.”
BackgroundInfluentialSGLT1 is a novel cardiac glucose transporter that is perturbed in disease states
Banerjee, S. K., McGaffin, K. R., Pastor-Soler, N. M., & Ahmad, F. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp190 · Cited by 221 · cited 7×
“It is worth noting that brain expression of SGLT1 has been proposed in other species, such as rats, mice, and pigs, using in situ hybridization and immunological and RT-PCR techniques.”
BackgroundMethodInfluentialSotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes
Sands, A. T., Zambrowicz, B. P., Rosenstock, J., Lapuerta, P., Bode, B. W., Garg, S. K., Buse, J. B., Banks, P., Heptulla, R., Rendell, M., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2806 · Cited by 220 · cited 2×
“[68,159,160] that is currently in clinical trials.”
BackgroundZierler, K. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.3.e409 · Cited by 217 · cited 2×
“[1,2] As a consequence, its homeostasis is finely regulated by various hormones, including insulin and glucagon.”
BackgroundMembrane Topology Motifs in the SGLT Cotransporter Family
Turk, E., & Wright, E. M. (1997) · The Journal of Membrane Biology · doi:10.1007/s002329900264 · Cited by 211 · cited 1×
“1, is a 664-amino-acid protein, which contains 14 transmembrane α-helical domains.[5,22] The glucosebinding domain of human SGLT1 is supposed to include amino acid residues 457–460.”
BackgroundHuman cardiomyocytes express high level of Na+/glucose cotransporter 1 (SGLT1)
Zhou, L., Cryan, E. V., D'Andrea, M. R., Belkowski, S., Conway, B. R., & Demarest, K. T. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10631 · Cited by 206 · cited 4×
“Human Small intestine Reverse transcription-polymerase chain reaction (RT-PCR) [26,28,30]; western blotting [28,31]; immunostaining [28,32]; northern blot [33] Kidney RT-PCR [26,28,34]; western Blotting [28]; immunostaining [28,32] Heart RT-PCR [26,34,35]; western Blotting [28,32,35]; immunostaining [28,32] Pancreatic…”
BackgroundMethodInfluentialDiabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage
Liu, Q., Wang, S., & Cai, L. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12250 · Cited by 206 · cited 1×
“apoptosis, activation of matrix metalloproteinases, and modulation of signal transduction pathways, which lead to cardiac dysfunction and hypertrophy.[150] Balteau and colleagues”
BackgroundVestri, S., Okamoto, M. M., de Freitas, H. S., Aparecida dos Santos, R., Nunes, M. T., Morimatsu, M., Heimann, J. C., & Machado, U. F. (2001) · Journal of Membrane Biology · doi:10.1007/s00232-001-0036-y · Cited by 191 · cited 2×
“Human Small intestine RT-PCR [116]/up Western Blotting [116]/up Heart RT-PCR [35]/up Mouse Duodenum RT-PCR [114]/up Kidney RT-PCR [38]/down Western blotting [38]/up; [37]/down Rat Small intestine RT-PCR [62]/up Kidney RT-PCR [118,119]/up Western blotting [120]/up; [121–123]/ unchanged Brain (ventromedial hypothalamus)…”
BackgroundMethodRegulation of Na+/Glucose Cotransporter Expression by Protein Kinases in Oocytes
Hirsch, J. R., Loo, D. D. F., & Wright, E. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.14740 · Cited by 190 · cited 4×
“Xenopus oocytes, expressed human SGLT1 was upregulated post-transcriptionally, whereas expressed rabbit and rat SGLT1 were downregulated by stimulation of PKC.[86,95] The short”
BackgroundInfluentialGembardt, F., Bartaun, C., Jarzebska, N., Mayoux, E., Todorov, V. T., Hohenstein, B., & Hugo, C. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00145.2014 · Cited by 189 · cited 5×
“expression but increased renal membrane SGLT1 protein expression.[38] A dissociation of the response in SGLT1 mRNA and protein expression indicates a complex translational and post-translation regulation.”
BackgroundMethodInfluentialAsghar, O., Alsunni, A. A., Khavandi, K., Khavandi, A., Withers, S., Greenstein, A. S., Heagerty, A. M., & Malik, R. A. (2009) · Clinical Science · doi:10.1042/cs20080500 · Cited by 187
KCNQ1-dependent transport in renal and gastrointestinal epithelia
Vallon, V., Grahammer, F., Volkl, H., Sandu, C. D., Richter, K., Rexhepaj, R., Gerlach, U., Rong, Q., Pfeifer, K., & Lang, F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505860102 · Cited by 185 · cited 13×
“[16] During modest hyperglycemia, selective renal SGLT1 inhibition alone would be expected to induce only a small increase in urinary glucose excretion because the glucose transport capacity of upstream SGLT2 becomes increasingly engaged under these conditions, such that small amounts of glucose are delivered to SGLT1.”
BackgroundInfluentialSelf-citationPowell, D. R., Smith, M., Greer, J., Harris, A., Zhao, S., DaCosta, C., Mseeh, F., Shadoan, M. K., Sands, A., Zambrowicz, B., et al. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.203364 · Cited by 184 · cited 4×
“[68,69,74,76] It has been proposed that bacterial fermentation of luminal glucose to short-chain-fatty-acids (SCFAs), which”
BackgroundInfluentialGouyon, F., Caillaud, L., Carrière, V., Klein, C., Dalet, V., Citadelle, D., Kellett, G. L., Thorens, B., Leturque, A., & Brot‐Laroche, E. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049247 · Cited by 183
SGLT2 inhibitors in the treatment of type 2 diabetes
Hasan, F. M., Alsahli, M., & Gerich, J. E. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.02.014 · Cited by 173
Regulation of Glucose Transporter SGLT1 by Ubiquitin Ligase Nedd4‐2 and Kinases SGK1, SGK3, and PKB
Dieter, M., Palmada, M., Rajamanickam, J., Aydin, A., Busjahn, A., Boehmer, C., Luft, F. C., & Lang, F. (2004) · Obesity Research · doi:10.1038/oby.2004.104 · Cited by 170 · cited 4×
“cose transport is upregulated by the serum and glucocorticoid-inducible kinase 1 (SGK1), and that this interaction involves the ubiquitin ligase Nedd4-2 [101] as well as the”
BackgroundInfluentialBalen, D., Ljubojević, M., Breljak, D., Brzica, H., Z̆lender, V., Koepsell, H., & Sabolić, I. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00180.2008 · Cited by 166 · cited 4×
“[5,126] As demonstrated in mice, rats, and humans, SGLT2 is expressed in the early part of the proximal tubules (S1/S2 segments), whereas SGLT1 is expressed in the more distal part (S2/S3 segments) of the proximal tubules [17,28,41] (Figure 2).”
BackgroundMethodInfluentialSelf-citationMarks, J., Carvou, N. J. C., Debnam, E. S., Srai, S. K., & Unwin, R. J. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.046268 · Cited by 166 · cited 1×
“the luminal brush border of the proximal tubule associated with an increase in facilitative glucose absorption.[135,136] Further studies are needed to define the relative relevance”
BackgroundWashburn, W. N. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8013019 · Cited by 160 · cited 10×
“[16] During modest hyperglycemia, selective renal SGLT1 inhibition alone would be expected to induce only a small increase in urinary glucose excretion because the glucose transport capacity of upstream SGLT2 becomes increasingly engaged under these conditions, such that small amounts of glucose are delivered to SGLT1.”
BackgroundInfluentialImproved glycemic control in mice lacking Sglt1 and Sglt2
Powell, D. R., DaCosta, C. M., Gay, J., Ding, Z.-M., Smith, M., Greer, J., Doree, D., Jeter-Jones, S., Mseeh, F., Rodriguez, L. A., et al. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00439.2012 · Cited by 158 · cited 4×
“Whereas selective SGLT2 inhibitors as well as LX4211 alone have very little risk for hypoglycemia,[7,159] more complete dual SGLT2/SGLT1 inhibition may increase the risk of hypoglycemia as indicated by murine studies.[16,18] This could be relevant, especially when other factors facilitating hypoglycemia are prevalent…”
BackgroundInfluentialMoriya, R., Shirakura, T., Ito, J., Mashiko, S., & Seo, T. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00412.2009 · Cited by 156 · cited 4×
“[15,63,73,74] In addition, alpha-gustducin-coupled T1R3”
BackgroundMethodInfluentialKowalski, G. M., & Bruce, C. R. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00165.2014 · Cited by 154 · cited 2×
“[1,2] As a consequence, its homeostasis is finely regulated by various hormones, including insulin and glucagon.”
BackgroundRegulation of sarcolemmal glucose and fatty acid transporters in cardiac disease
Schwenk, R. W., Luiken, J. J. F. P., Bonen, A., & Glatz, J. F. C. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn116 · Cited by 147 · cited 1×
“[141] In addition to these GLUTs, SGLT1 was found to be strongly expressed in the heart, including in cell membranes”
BackgroundGarvey, W. T., Hardin, D. S., Juhaszova, M., & Dominguez, J. H. (1993) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1993.264.3.h837 · Cited by 147 · cited 1×
“[144] In STZ-induced T1DM rats, GLUT4 mRNA and protein expression as well as glucose uptake in the heart were decreased, and restored by insulin administration, whereas GLUT1 mRNA expression was not significantly altered.[142,145] Contractile dysfunction was evident in the hearts of T2DM db/db mice; this was associate…”
BackgroundYoshikawa, T., Inoüe, R., Matsumoto, M., Yajima, T., Ushida, K., & Iwanaga, T. (2011) · Histochemistry and Cell Biology · doi:10.1007/s00418-011-0779-1 · Cited by 146 · cited 3×
“It is worth noting that brain expression of SGLT1 has been proposed in other species, such as rats, mice, and pigs, using in situ hybridization and immunological and RT-PCR techniques.”
MethodSchulze, C., Bangert, A., Kottra, G., Geillinger, K. E., Schwanck, B., Vollert, H., Blaschek, W., & Daniel, H. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400016 · Cited by 146 · cited 1×
“blood glucose levels in rodents and humans.[158,166] Notably,”
BackgroundRole of KCNE1-Dependent K+ Fluxes in Mouse Proximal Tubule
VALLON, V., GRAHAMMER, F., RICHTER, K., BLEICH, M., LANG, F., BARHANIN, J., VÖLKL, H., & WARTH, R. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12102003 · Cited by 145
Self-citationWALKER, J., JIJON, H. B., DIAZ, H., SALEHI, P., CHURCHILL, T., & MADSEN, K. L. (2005) · Biochemical Journal · doi:10.1042/bj20040694 · Cited by 145 · cited 1×
“dependent SGLT1, which may reflect the role of AMPK as a key sensor of energy status within the cell.[100] Xenopus oocytes studies showed that SGLT1-mediated glu-”
BackgroundProtein in optimal health: heart disease and type 2 diabetes
Layman, D. K., Clifton, P., Gannon, M. C., Krauss, R. M., & Nuttall, F. Q. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1571s · Cited by 142 · cited 1×
“[68,74] High-carbohydrate diets (55–60% of energy) had been standard recommendations for management of T2DM for a long time but this has been questioned more recently, in particular in relation to protein intake.[117] Along these lines, we observed in preliminary studies that the application of an equicaloric glucose…”
ResultExpression of the Na+‐d‐Glucose Cotransporter SGLT1 in Neurons
Poppe, R., Karbach, U., Gambaryan, S., Wiesinger, H., Lutzenburg, M., Kraemer, M., Witte, O. W., & Koepsell, H. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010084.x · Cited by 134 · cited 4×
“Rabbit Small intestine Situ hybridization [57]; northern blot [21,33]; western blotting [31,58]; immunostaining [57] Kidney Northern blot [31,33]; western blot [31] Brain RT-PCR [29]; situ hybridization [29,58] Heart Northern blot [21] Pleura Western Blotting [59] Pig Brain RT-PCR [29]; situ hybridization [29]; wester…”
MethodInfluentialSelf-citationHan, H. J., Lee, Y. J., Park, S. H., Lee, J. H., & Taub, M. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00327.2004 · Cited by 132 · cited 1×
“[140] In the porcine renal epithelial cell line LLC-PK1 transcriptional downregulation of SGLT1 occurred after cultivation with 25 mM glucose versus 5 mM glucose; this was”
MethodYarandi, S. S., Hebbar, G., Sauer, C. G., Cole, C. R., & Ziegler, T. R. (2011) · Nutrition · doi:10.1016/j.nut.2010.07.004 · Cited by 132 · cited 1×
“derived ‘satiety hormone’, has also been implicated in the regulation of intestinal glucose absorption,[112] and leptin administration to rats, especially from the lumen, rapidly”
BackgroundConsumption of added sugars among U.S. adults, 2005-2010.
Ervin, R. B., & Ogden, C. L. (2013) · PubMed · Cited by 129
Regional distribution of SGLT activity in rat brain in vivo
Yu, A. S., Hirayama, B. A., Timbol, G., Liu, J., Diez-Sampedro, A., Kepe, V., Satyamurthy, N., Huang, S.-C., Wright, E. M., & Barrio, J. R. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00317.2012 · Cited by 126 · cited 1×
“when extracellular concentrations are low, such as in ischemia.[53] 4.”
BackgroundPhysiology of Incretins in Health and Disease
Deacon, C. F., & Ahrén, B. (2011) · The Review of Diabetic Studies · doi:10.1900/rds.2011.8.293 · Cited by 126 · cited 1×
“In addition to protein and fat, the ingestion of glucose induces the secretion of the incretins, glucagon-like peptide 1 (GLP1) and glucose-dependent insulinotropic peptide (GIP), from intestinal L cells and K cells, respectively.[70,71] These hormones then act on pancreatic β cells to increase insulin”
BackgroundGLUCOSE-GALACTOSE MALABSORPTION
Lindquist, B., Mbeuwisse, G., & Melin, K. (1962) · The Lancet · doi:10.1016/s0140-6736(62)92582-5 · Cited by 126
Regulation of the human Na+-dependent glucose cotransporter hSGLT2
Ghezzi, C., & Wright, E. M. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00115.2012 · Cited by 124 · cited 1×
“SGLT2 activity, but human SGLT1 was relatively insensitive to insulin.[137] SGK1 has been proposed to be upregulated”
BackgroundFunctional expression of SGLTs in rat brain
Yu, A. S., Hirayama, B. A., Timbol, G., Liu, J., Basarah, E., Kepe, V., Satyamurthy, N., Huang, S.-C., Wright, E. M., & Barrio, J. R. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00296.2010 · Cited by 123
McGuire, S. (2012) · Advances in Nutrition · doi:10.3945/an.112.002279 · Cited by 121
Metabolic Substrates, Cellular Energy Production, and the Regulation of Proximal Tubular Transport
Mandel, L. J. (1985) · Annual Review of Physiology · doi:10.1146/annurev.ph.47.030185.000505 · Cited by 119 · cited 1×
“[125] Glucose is transported across the apical membrane of”
BackgroundRhoads, D. B., Rosenbaum, D. H., Unsal, H., Isselbacher, K. J., & Levitsky, L. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9510 · Cited by 117
Kashiwagi, Y., Nagoshi, T., Yoshino, T., Tanaka, T. D., Ito, K., Harada, T., Takahashi, H., Ikegami, M., Anzawa, R., & Yoshimura, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130605 · Cited by 117 · cited 6×
“the Langendorff model.[32] Banerjee and colleagues provided first evidence that the increase in cardiac glucose uptake induced by insulin and leptin in cultured mouse”
BackgroundMethodInfluentialEnteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery
Holst, J. J. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.09.014 · Cited by 116 · cited 4×
“A major defect in T2DM is a reduction of the insulinotropic response to GLP-1 and GIP in the pancreas, which can be overcome by higher doses of GLP-1.[124] In addition, the”
BackgroundInfluentialMolecular adaptations of GLUT1 and GLUT2 in renal proximal tubules of diabetic rats
Dominguez, J. H., Camp, K., Maianu, L., Feister, H., & Garvey, W. T. (1994) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1994.266.2.f283 · Cited by 114
Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update
Novikov, A., & Vallon, V. (2015) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000187 · Cited by 114 · cited 1×
“The compounds induce a modest diuresis/natriuresis, urinary calorie loss, and activation of lipolysis, which are associated with a modest reduction in body fat, body weight, and blood pressure.[12] Ongoing long-term clinical trials explore the safety and the clinical efficacy of SGLT2 inhibitors in the prevention of d…”
BackgroundSelf-citationHwang, E.-S. S., Hirayama, B. A., & Wright, E. M. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)92067-t · Cited by 113 · cited 2×
“[28,40,42,46,57,58] and is responsible for the transport of glucose and galactose from the lumen into the epithelial cells; whereas facilitative GLUTs, especially GLUT2, subsequently”
BackgroundMethodDucroc, R., Guilmeau, S., Akasbi, K., Devaud, H., Buyse, M., & Bado, A. (2005) · Diabetes · doi:10.2337/diabetes.54.2.348 · Cited by 112 · cited 1×
“reduced luminal SGLT1 expression and glucose uptake [113]”
BackgroundBalteau, M., Tajeddine, N., de Meester, C., Ginion, A., Des Rosiers, C., Brady, N. R., Sommereyns, C., Horman, S., Vanoverschelde, J.-L., Gailly, P., et al. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr230 · Cited by 111 · cited 1×
“[151] Notably, cardiac mRNA expression of SGLT1 has been”
BackgroundT1r3 and α‐Gustducin in Gut Regulate Secretion of Glucagon‐like Peptide‐1
Kokrashvili, Z., Mosinger, B., & Margolskee, R. F. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04485.x · Cited by 110
Pereira, R. O., Wende, A. R., Olsen, C. D., Soto, J. E., Rawlings, T. A., Zhu, Y., Anderson, S. M., & Abel, E. D. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000301 · Cited by 110
Dobbins, R. L., Greenway, F. L., Chen, L., Liu, Y., Breed, S. L., Andrews, S. M., Wald, J. A., Walker, A., & Smith, C. D. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00286.2014 · Cited by 107
Enhanced expressions of sodium–glucose cotransporters in the kidneys of diabetic Zucker rats
Tabatabai, N. M., Sharma, M., Blumenthal, S. S., & Petering, D. H. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.11.003 · Cited by 106 · cited 4×
“in diabetic obese Zucker rats were higher than in agematched non-diabetic lean rats.[119] BTBR ob/ob T2DM mice have been reported to have lower SGLT1 mRNA”
BackgroundMethodInfluentialTakata, K., Kasahara, T., Kasahara, M., Ezaki, O., & Hirano, H. (1991) · Journal of Histochemistry & Cytochemistry · doi:10.1177/39.3.1993828 · Cited by 97 · cited 2×
“[28,40,42,46,57,58] and is responsible for the transport of glucose and galactose from the lumen into the epithelial cells; whereas facilitative GLUTs, especially GLUT2, subsequently”
BackgroundMethodI. Glucose Galactose Malabsorption
Wright, E. M. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.275.5.g879 · Cited by 95 · cited 1×
“[4,15,170] To prevent these side effects, SGLT2 inhibitors”
BackgroundComparative gene expression profiles of intestinal transporters in mice, rats and humans
Kim, H., Park, S., Cho, H.-J., Chae, K.-A., Sung, J.-M., Kim, J.-S., Landowski, C. P., Sun, D., El‐Aty, A. M. A., Amidon, G. L., et al. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.06.005 · Cited by 94 · cited 4×
“Human Small intestine Reverse transcription-polymerase chain reaction (RT-PCR) [26,28,30]; western blotting [28,31]; immunostaining [28,32]; northern blot [33] Kidney RT-PCR [26,28,34]; western Blotting [28]; immunostaining [28,32] Heart RT-PCR [26,34,35]; western Blotting [28,32,35]; immunostaining [28,32] Pancreatic…”
MethodInfluentialNutrient regulation of human intestinal sugar transporter (SGLT1) expression.
Dyer, J., Hosie, K. B., & Shirazi-Beechey, S. P. (1997) · Gut · doi:10.1136/gut.41.1.56 · Cited by 93 · cited 1×
“[79,80,82] The sweet taste receptor subunit T1R3 and the taste G protein gustducin, expressed in enteroendocrine L-cells, are involved in intestinal sensing of dietary sugar and artificial sweeteners which subsequently upregulates intestinal SGLT1 mRNA and protein expression.”
BackgroundBanerjee, S., Wang, D. W., Alzamora, R., Huang, X. N., Pastor‐Soler, N. M., Hallows, K. R., McGaffin, K. R., & Ahmad, F. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.06.003 · Cited by 93 · cited 1×
“[154,155] The relevance of this finding for the diabetic heart”
BackgroundThe gut endocrine system as a coordinator of postprandial nutrient homoeostasis
Gribble, F. M. (2012) · Proceedings of the Nutrition Society · doi:10.1017/s0029665112000705 · Cited by 89 · cited 1×
“In addition to protein and fat, the ingestion of glucose induces the secretion of the incretins, glucagon-like peptide 1 (GLP1) and glucose-dependent insulinotropic peptide (GIP), from intestinal L cells and K cells, respectively.[70,71] These hormones then act on pancreatic β cells to increase insulin”
BackgroundFujita, Y., Kojima, H., Hidaka, H., Fujimiya, M., Kashiwagi, A., & Kikkawa, R. (1998) · Diabetologia · doi:10.1007/s001250051092 · Cited by 88 · cited 1×
“and occurred before the development of insulin resistance and hyperinsulinemia.[115] Most importantly, small intestinal SGLT1 mRNA expression and brush border membrane SGLT1 protein expression and intestinal glucose uptake were also found to be increased in patients with noninsulin-dependent diabetes mellitus.”
BackgroundAdachi, T., Yasuda, K., Okamoto, Y., Shihara, N., Oku, A., Ueta, K., Kitamura, K., Saito, A., Iwakura, T., Yamada, Y., et al. (2000) · Metabolism · doi:10.1053/meta.2000.7729 · Cited by 87
Castañeda, F., Burse, A., Boland, W., & Kinne, R. K.-H. (2007) · International Journal of Medical Sciences · doi:10.7150/ijms.4.131 · Cited by 87 · cited 5×
“SGLT1 but not SGLT2.[157,162,163] The development of EXPERT OPINION ON THERAPEUTIC TARGETS 1117”
BackgroundInfluentialDiabetes and glucose transporter gene expression in rat small intestine
Miyamoto, K., Hase, K., Taketani, Y., Minami, H., Oka, T., Nakabou, Y., & Hagihira, H. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)92053-m · Cited by 86 · cited 4×
“Human Small intestine RT-PCR [116]/up Western Blotting [116]/up Heart RT-PCR [35]/up Mouse Duodenum RT-PCR [114]/up Kidney RT-PCR [38]/down Western blotting [38]/up; [37]/down Rat Small intestine RT-PCR [62]/up Kidney RT-PCR [118,119]/up Western blotting [120]/up; [121–123]/ unchanged Brain (ventromedial hypothalamus)…”
BackgroundMethodInfluentialOverexpression of GLUT2 gene in renal proximal tubules of diabetic Zucker rats.
Kamran, M., Peterson, R. G., & Dominguez, J. H. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v86943 · Cited by 86
Intestinal glucose sensing and regulation of intestinal glucose absorption
Dyer, J., Daly, K., Salmon, K. S. H., Arora, D. K., Kokrashvili, Z., Margolskee, R. F., & Shirazi-Beechey, S. P. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351191 · Cited by 85 · cited 1×
“[79,80,82] The sweet taste receptor subunit T1R3 and the taste G protein gustducin, expressed in enteroendocrine L-cells, are involved in intestinal sensing of dietary sugar and artificial sweeteners which subsequently upregulates intestinal SGLT1 mRNA and protein expression.[83,84] Short-term upre-”
BackgroundShibazaki, T., Tomae, M., Ishikawa-Takemura, Y., Fushimi, N., Itoh, F., Yamada, M., & Isaji, M. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.193045 · Cited by 84 · cited 5×
“inhibitor and has inhibition constant values (Ki) of 97 and 13,600 nM for human SGLT1 and SGLT2, respectively (~1:140).[76] GSK-1614235 is an analog of KGA-2727 with Ki values of 27 and 8170 nM for human SGLT1 and SGLT2,”
BackgroundMethodInfluentialLocalization of the Na + -d-glucose cotransporter SGLT1 in the blood-brain barrier
Elfeber, K., K�hler, A., Lutzenburg, M., Osswald, C., Galla, H.-J., Witte, O. W., & Koepsell, H. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0633-9 · Cited by 82
Self-citationPost-challenge hyperglycaemia is associated with premature death and macrovascular complications
Qiao, Q., Tuomilehto, J. O., & Borch‐Johnsen, K. (2003) · Diabetologia · doi:10.1007/s00125-002-0932-4 · Cited by 81 · cited 1×
“[164,165] As discussed earlier, glucose absorption from the”
BackgroundGoodwin, N. C., Mabon, R., Harrison, B. A., Shadoan, M. K., Almstead, Z. Y., Xie, Y., Healy, J. P., Buhring, L., DaCosta, C. M., Bardenhagen, J., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900951n · Cited by 81
Ramratnam, M., Sharma, R. K., D’Auria, S., Lee, S., Wang, D., Huang, X. Y. N., & Ahmad, F. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.000899 · Cited by 80 · cited 1×
“[154,155] The relevance of this finding for the diabetic heart”
BackgroundSequence homologies among intestinal and renal Na+/glucose cotransporters
Coady, M. J., Pajor, A. M., & Wright, E. M. (1990) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1990.259.4.c605 · Cited by 80 · cited 3×
“Rabbit Small intestine Situ hybridization [57]; northern blot [21,33]; western blotting [31,58]; immunostaining [57] Kidney Northern blot [31,33]; western blot [31] Brain RT-PCR [29]; situ hybridization [29,58] Heart Northern blot [21] Pleura Western Blotting [59] Pig Brain RT-PCR [29]; situ hybridization [29]; wester…”
MethodImmunohistochemical localization of Na+-dependent glucose transporter in rat jejunum
Takata, K., Kasahara, T., Kasahara, M., Ezaki, O., & Hirano, H. (1992) · Cell and Tissue Research · doi:10.1007/bf00318685 · Cited by 79 · cited 1×
“[28,40,42,46,57,58] and is responsible for the transport of glucose and galactose from the lumen into the epithelial cells; whereas facilitative GLUTs, especially GLUT2, subsequently”
BackgroundOguma, T., Nakayama, K., Kuriyama, C., Matsushita, Y., Yoshida, K., Hikida, K., Obokata, N., Tsuda-Tsukimoto, M., Saito, A., Arakawa, K., et al. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.225508 · Cited by 78 · cited 1×
“[68] The promotion of GLP-1 secretion by transient inhibition of intestinal SGLT1 was also observed using phlorizin or canagliflozin in rodents [73,168] as well as more recently with GSK1614235 in healthy human subjects.”
BackgroundRegulation of the human Na+-glucose cotransporter gene,SGLT1, by HNF-1 and Sp1
Martín, M. G., Wang, J., Solorzano-Vargas, R. S., Lam, J. T., Turk, E., & Wright, E. M. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.4.g591 · Cited by 77 · cited 1×
“cells.[93] Studies in Xenopus oocytes and Chinese hamster”
BackgroundDiurnal rhythmicity in intestinal SGLT-1 function,Vmax, and mRNA expression topography
Tavakkolizadeh, A., Berger, U. V., Shen, K. R., Levitsky, L. L., Zinner, M. J., Hediger, M. A., Ashley, S. W., Whang, E. E., & Rhoads, D. B. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.280.2.g209 · Cited by 76
Lazaridis, K. N., Pham, L., Vroman, B., de Groen, P. C., & LaRusso, N. F. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.272.5.g1168 · Cited by 74 · cited 3×
“It is worth noting that brain expression of SGLT1 has been proposed in other species, such as rats, mice, and pigs, using in situ hybridization and immunological and RT-PCR techniques.”
MethodPKC regulates turnover rate of rabbit intestinal Na+-glucose transporter expressed in COS-7 cells
Vayro, S., & Silverman, M. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.276.5.c1053 · Cited by 73 · cited 1×
“term regulation of SGLT1 comprising effects on membrane trafficking and on transport function.[86,95,106,107] In”
BackgroundRegulation of Na+-coupled glucose carrier SGLT1 by AMP-activated protein kinase
Sopjani, M., Bhavsar, S. K., Fraser, S. A., Kemp, B. E., Föller, M., & Lang, F. J. W. (2010) · Molecular Membrane Biology · doi:10.3109/09687681003616870 · Cited by 70 · cited 1×
“[97] Studies using a similar approach indicated that activation of AMP-activated protein kinase (AMPK) increases SGLT1 membrane expression and activity.[98] AMPK has been implicated in the upregulation of intestinal glucose absorption in piglets in response to feeding long-chain n–3 polyunsaturated fatty acids, which…”
BackgroundIntestinal and renal Na+/glucose cotransporters share common structures
Hirayama, B. A., Wong, H. C., Smith, C. D., Hagenbuch, B. A., Hediger, M. A., & Wright, E. M. (1991) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1991.261.2.c296 · Cited by 69 · cited 2×
“[28,40,42,46,57,58] and is responsible for the transport of glucose and galactose from the lumen into the epithelial cells; whereas facilitative GLUTs, especially GLUT2, subsequently”
BackgroundMethodGabler, N. K., Radcliffe, J. S., Spencer, J. D., Webel, D. M., & Spurlock, M. E. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.11.009 · Cited by 67 · cited 1×
“[98] AMPK has been implicated in the upregulation of intestinal glucose absorption in piglets in response to feeding long-chain n–3 polyunsaturated fatty acids, which was associated with increased GLUT2 and SGLT1 expression, indicating long-term regulation involving changes in transcription.[99] In contrast, studies i…”
BackgroundSchmidt, U., Eddy, B. J., Fraser, C. M., Venter, J. C., & Semenza, G. (1983) · FEBS Letters · doi:10.1016/0014-5793(83)81025-4 · Cited by 62 · cited 1×
“cotransporter as a 73-kDa protein through a series of experiments using azido–phlorizin-photoaffinity labeling and antibodies.[19,20] In 1987, Wright and co-workers cloned SGLT1 from rabbit.”
BackgroundPeerce, B. E., & Wright, E. M. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.7.2223 · Cited by 62 · cited 1×
“cotransporter as a 73-kDa protein through a series of experiments using azido–phlorizin-photoaffinity labeling and antibodies.[19,20] In 1987, Wright and co-workers cloned SGLT1 from rabbit.”
BackgroundOsswald, C., Baumgarten, K., Stümpel, F., Gorboulev, V., Akimjanova, M., Knobeloch, K.-P., Horak, I., Kluge, R., Joost, H.-G., & Koepsell, H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.78-87.2005 · Cited by 59 · cited 1×
“In RS1 knockout mice, the amount of SGLT1 in the plasma membrane is increased at low intracellular glucose and no further increase is observed at high intracellular glucose.[89,108] Thus, upregulation of SGLT1 expression in small intestine after glucose ingestion is promoted by glucose dependent disinhibition of the R…”
BackgroundSelf-citationEffect of LX4211 on Glucose Homeostasis and Body Composition in Preclinical Models
Powell, D. R., DaCosta, C. M., Smith, M. G., Doree, D. D., Harris, A. L., Buhring, L., Heydorn, W. E., Nouraldeen, A. M., Xiong, W., Yalamanchili, P., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.214304 · Cited by 58 · cited 1×
“and by studies using a potent dual SGLT2/SGLT1 inhibitor.[131] Based on renal glucose reabsorption studies in gene-targeted”
BackgroundSodium–glucose transport: role in diabetes mellitus and potential clinical implications
Vallon, V., & Sharma, K. (2010) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0b013e32833bec06 · Cited by 57 · cited 2×
“through the basolateral membrane by the facilitative GLUTs – GLUT2 and GLUT1.[5,126] As demonstrated in mice, rats, and humans, SGLT2 is expressed in the early part of the proximal tubules (S1/S2 segments), whereas SGLT1 is expressed in the more distal part (S2/S3 segments) of the proximal tubules [17,28,41] (Figure 2…”
BackgroundSelf-citationCardiomyocyte glycophagy is regulated by insulin and exposure to high extracellular glucose
Mellor, K. M., Varma, U., Stapleton, D. I., & Delbridge, L. M. D. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00059.2014 · Cited by 56 · cited 3×
“[153] Furthermore, STZ-diabetic T1DM rats have increased cardiac expression of autophagy proteins that are specific for glycogen.[152] Interestingly in this regard, cardiac-”
BackgroundIntestinal function of gene-targeted mice lacking serum- and glucocorticoid-inducible kinase 1
Grahammer, F., Henke, G., Sandu, C., Rexhepaj, R., Hussain, A., Friedrich, B., Risler, T., Metzger, M., Just, L., Skutella, T., et al. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00231.2005 · Cited by 56
Petersen, C. (1835) · Annalen der Pharmacie · doi:10.1002/jlac.18350150210 · Cited by 54
Cai, Q., Li, B., Yu, F., Lu, W., Zhang, Z., Yin, M., & Gao, H. (2013) · Journal of Diabetes Research · doi:10.1155/2013/263845 · Cited by 54 · cited 1×
“cardiac damage; this was associated with a decrease in blood glucose, body weight, triglyceride, total cholesterol, and advanced glycation end products.[173] These findings suggest”
BackgroundPereira, R. O., Wende, A. R., Olsen, C. D., Soto, J. E., Rawlings, T. A., Zhu, Y., Riehle, C., & Abel, E. D. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.02.011 · Cited by 53
Sabolić, I., Škarica, M., Gorboulev, V., Ljubojević, M., Balen, D., Herak-Kramberger, C. M., & Koepsell, H. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00270.2005 · Cited by 51 · cited 3×
“It is worth noting that brain expression of SGLT1 has been proposed in other species, such as rats, mice, and pigs, using in situ hybridization and immunological and RT-PCR techniques.”
MethodSelf-citationApical NA+/H+ exchangers in the mammalian gastrointestinal tract.
Kiela, P. R., Xu, H. J., & Ghishan, F. K. (2006) · PubMed · Cited by 49
Effect of Long-Term Type 1 Diabetes on Renal Sodium and Water Transporters in Rats
Vidotti, D. B., Arnoni, C. P., Maquigussa, E., & Boim, M. A. (2007) · American Journal of Nephrology · doi:10.1159/000109967 · Cited by 48 · cited 2×
“Human Small intestine RT-PCR [116]/up Western Blotting [116]/up Heart RT-PCR [35]/up Mouse Duodenum RT-PCR [114]/up Kidney RT-PCR [38]/down Western blotting [38]/up; [37]/down Rat Small intestine RT-PCR [62]/up Kidney RT-PCR [118,119]/up Western blotting [120]/up; [121–123]/ unchanged Brain (ventromedial hypothalamus)…”
RS1 (RSC1A1) regulates the exocytotic pathway of Na+-d-glucose cotransporter SGLT1
Veyhl, M., Keller, T., Gorboulev, V., Vernaleken, A., & Koepsell, H. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00068.2006 · Cited by 47
Self-citationSilva, R. S., Freitas, H. S., Lamers, M. L., Okamoto, M. M., dos Santos, M. F., & Machado, U. F. (2009) · The Journal of Membrane Biology · doi:10.1007/s00232-009-9159-3 · Cited by 46 · cited 2×
“human parotid and submandibular salivary glands, liver, lung, skeletal muscle, heart, and pancreatic alpha cells.[21,27,40,55]”
BackgroundMethodSubramanian, S., Glitz, P., Kipp, H., Kinne, R. K.-H., & Castañeda, F. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22025 · Cited by 46 · cited 1×
“changes in the conformation of the empty carrier and the glucose carrier complex.[94,95] Studies in Madin–Darby canine kidney (MDCK) cells confirmed that SGLT1 protein is upregulated by a cAMP-PKA dependent pathway, a response that required intact actin filaments, suggesting involvement of vesicle trafficking, probabl…”
BackgroundChaudhry, R. M., Scow, J. S., Madhavan, S., Duenes, J. A., & Sarr, M. G. (2011) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-011-1752-y · Cited by 45
Albertoni Borghese, M. F., Majowicz, M. P., Ortiz, M. C., del Rosario Passalacqua, M., Sterin Speziale, N. B., & Vidal, N. A. (2009) · Nephron Physiology · doi:10.1159/000214214 · Cited by 43 · cited 1×
“[37] Other studies found unchanged renal SGLT1 protein expression [121–123] or reduced renal expression and activity of SGLT1 [134] in diabetic rodent models.”
BackgroundKATP channel as well as SGLT1 participates in GIP secretion in the diabetic state
Ogata, H., Seino, Y., Harada, N., Iida, A., Suzuki, K., Izumoto, T., Ishikawa, K., Uenishi, E., Ozaki, N., Hayashi, Y., et al. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0161 · Cited by 42 · cited 6×
“[114] and rats [62] with STZ-induced diabetes, a model of hyperphagic type I diabetes (T1DM).”
BackgroundMethodInfluentialVeyhl, M., Wagner, C. A., Gorboulev, V., Schmitt, B. M., Lang, F. J. W., & Koepsell, H. (2003) · The Journal of Membrane Biology · doi:10.1007/s00232-003-0626-y · Cited by 41
Self-citationGoestemeyer, A., Marks, J., Srai, S. K., Debnam, E. S., & Unwin, R. J. (2007) · Diabetologia · doi:10.1007/s00125-007-0778-x · Cited by 38 · cited 1×
“the luminal brush border of the proximal tubule associated with an increase in facilitative glucose absorption.[135,136] Further studies are needed to define the relative relevance”
BackgroundShearer, J., Ross, K. D., Hughey, C. C., Johnsen, V. L., Hittel, D. S., & Severson, D. L. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00525.2010 · Cited by 37 · cited 2×
“transport and glycogen accumulation [152,153] as well as the in vivo physiological and pathophysiological role of cardiac”
BackgroundVernaleken, A., Veyhl, M., Gorboulev, V., Kottra, G., Palm, D., Burckhardt, B. C., Burckhardt, G., Pipkorn, R., Beier, N., van Amsterdam, C., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705416200 · Cited by 37
Self-citationShojaeifard, M. B., Strutz‐Seebohm, N., Tavaré, J. M., Seebohm, G., & Lang, F. J. W. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.111 · Cited by 37 · cited 2×
“phosphatidylinositol-3-phosphate-5-kinase PIKfyve.[102]”
Haase, W., & Koepsell, H. (1989) · PubMed · Cited by 35
Self-citationTransporter regulator RS1 (RSC1A1) coats thetrans-Golgi network and migrates into the nucleus
Kroiß, M., Leyerer, M., Gorboulev, V., Kühlkamp, T., Kipp, H., & Koepsell, H. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00067.2006 · Cited by 34 · cited 3×
“[83,84] Short-term upregulation of SGLT1 in the brush–border membrane within minutes after glucose ingestion includes the activation and release of SGLT1 containing vesicles from the trans-Golgi network (TGN).”
BackgroundInfluentialSelf-citationDifferential Regulation of Mouse Kidney Sodium-Dependent Transporters mRNA by Cadmium
Tabatabai, N. M., Blumenthal, S. S., Lewand, D. L., & Petering, D. H. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9321 · Cited by 34
Na+–d-glucose cotransporter in muscle capillaries increases glucose permeability
Elfeber, K., Stümpel, F. T., Gorboulev, V., Mattig, S., Deußen, A., Kaissling, B., & Koepsell, H. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.090 · Cited by 34 · cited 2×
“not in capillaries of the small intestine had previously been reported by immunohistochemistry in rats.[56] More”
BackgroundMethodSelf-citationSGK1-sensitive renal tubular glucose reabsorption in diabetes
Ackermann, T. F., Boini, K. M., Völkl, H., Bhandaru, M., Bareiss, P. M., Just, L., Vallon, V., Amann, K., Kuhl, D., Feng, Y., et al. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90238.2008 · Cited by 33 · cited 2×
“in the diabetic kidney in rodents and humans.[138,139] Studies in T1DM Akita mice lacking SGK1 indicated that the kinase may stimulate electrogenic glucose transport in”
BackgroundSelf-citationDecreased intestinal glucose transport in the sgk3-knockout mouse
Sandu, C. D., Rexhepaj, R., Grahammer, F., McCormick, J. A., Henke, G., Palmada, M., Nammi, S., Lang, U. E., Metzger, M., Just, L., et al. (2005) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-005-1474-7 · Cited by 32 · cited 1×
“transport of phenylalanine, cysteine, glutamine and proline were not affected in Sgk3−/− mice [105] (Figure 1).”
BackgroundKorn, T., Kühlkamp, T., Track, C., Schatz, I., Baumgarten, K., Gorboulev, V., & Koepsell, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105975200 · Cited by 31
Self-citationDoes apical membrane GLUT2 have a role in intestinal glucose uptake?
Naftalin, R. J. (2014) · F1000Research · doi:10.12688/f1000research.5934.1 · Cited by 27
Haase, W., Heitmann, K., Friese, W., Ollig, D., & Koepsell, H. (1990) · PubMed · Cited by 27
Self-citationVeyhl-Wichmann, M., Friedrich, A., Vernaleken, A., Singh, S., Kipp, H., Gorboulev, V., Keller, T., Chintalapati, C., Pipkorn, R., Pastor‐Anglada, M., et al. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.101162 · Cited by 24 · cited 3×
“[86] RS1 which is located at the transGolgi network (TGN) [87] binds to a receptor at the TGN containing a glucose binding site that blocks the release of SGLT1 containing vesicles from the TGN at low intracellular glucose concentrations.[89] At high-intracellular glucose concentrations the RS1-induced blockade of ves…”
BackgroundSelf-citationFan, X., Chan, O. T. M., Ding, Y., Zhu, W., Mastaitis, J. W., & Sherwin, R. (2015) · Diabetes · doi:10.2337/db15-0022 · Cited by 23 · cited 6×
“taining the SGLT1 short hairpin RNA (shRNA).[51] The results”
BackgroundMethodInfluentialFushimi, N., Fujikura, H., Shiohara, H., Teranishi, H., Shimizu, K., Yonekubo, S., Ohno, K., Miyagi, T., Itoh, F., Shibazaki, T., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.09.037 · Cited by 23 · cited 4×
“Other studies also indicated the feasibility to develop molecules that inhibit SGLT1 but not SGLT2.”
BackgroundInfluentialCastaneda‐Sceppa, C., Subramanian, S., & Castañeda, F. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22489 · Cited by 22 · cited 1×
“term regulation of SGLT1 comprising effects on membrane trafficking and on transport function.[86,95,106,107] In”
BackgroundRegulation of SGLT1 expression in response to Na+ intake
Barfull, A., Garriga, C., Tauler, A., & Planas, J. M. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00263.2001 · Cited by 21 · cited 1×
“[79,80,82] The sweet taste receptor subunit T1R3 and the taste G protein gustducin, expressed in enteroendocrine L-cells, are involved in intestinal sensing of dietary sugar and artificial sweeteners which subsequently upregulates intestinal SGLT1 mRNA and protein expression.”
BackgroundFilatova, A., Leyerer, M., Gorboulev, V., Chintalapati, C., Reinders, Y., Müller, T. D., Srinivasan, A., Hubner, S. E., & Koepsell, H. (2009) · Traffic · doi:10.1111/j.1600-0854.2009.00982.x · Cited by 18 · cited 4×
“Employing the porcine renal epithelial cell line LLC-PK1 expressing SGLT1 and RS1 it was observed that transcriptional downregulation of SGLT1 after cultivation with 25 mM glucose versus 5 mM glucose was dependent on the presence of RS1.”
BackgroundInfluentialSelf-citationFushimi, N., Teranishi, H., Shimizu, K., Yonekubo, S., Ohno, K., Miyagi, T., Itoh, F., Shibazaki, T., Tomae, M., Ishikawa-Takemura, Y., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.11.041 · Cited by 17 · cited 4×
“Other studies also indicated the feasibility to develop molecules that inhibit SGLT1 but not SGLT2.”
BackgroundInfluentialIkari, A., Harada, H., & Takagi, K. (2005) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2005.02.008 · Cited by 14 · cited 1×
“[94,95] Studies in Madin–Darby canine kidney (MDCK) cells confirmed that SGLT1 protein is upregulated by a cAMP-PKA dependent pathway, a response that required intact actin filaments, suggesting involvement of vesicle trafficking, probably the exocytotic pathway.[96] The in vivo relevance of PKA-regulated SGLT1 regula…”
BackgroundLP ‐925219 maximizes urinary glucose excretion in mice by inhibiting both renal SGLT 1 and SGLT 2
Powell, D. R., Smith, M. G., Doree, D. D., Harris, A. L., Xiong, W., Mseeh, F., Wilson, A., Gopinathan, S., Diaz, D. S., Goodwin, N. C., et al. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.129 · Cited by 13 · cited 2×
“sotagliflozin (IC50 ratio for mouse SGLT1:SGLT2 of 45:1).[161] The pyrazole-O-glucoside KGA-2727 is the first selective SGLT1”
BackgroundSPAK-Sensitive Regulation of Glucose Transporter SGLT1
Elvira, B., Blecua, M., Luo, D., Yang, W., Shumilina, E. V., Muñoz, C., & Lang, F. J. W. (2014) · The Journal of Membrane Biology · doi:10.1007/s00232-014-9719-z · Cited by 12 · cited 1×
“mediated glucose transport in Xenopus oocytes and mouse intestine is ‘with-no-K[Lys] kinases’/STE20/SPS1-related proline/alanine-rich kinase (SPAK).[111] Leptin, an adipocyte-”
BackgroundUp-regulation of Na+-coupled glucose transporter SGLT1 by caveolin-1
Elvira, B., Honisch, S., Almilaji, A., Pakladok, T., Liu, G., Shumilina, E. V., Alesutan, I., Yang, W., Munoz, C., & Lang, F. J. W. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.06.007 · Cited by 12 · cited 1×
“[97] Studies using a similar approach indicated that activation of AMP-activated protein kinase (AMPK) increases SGLT1 membrane expression and activity.”
Background
Cited by
Vallon, V., & Thomson, S. C. (2017) · Diabetologia · doi:10.1007/s00125-016-4157-3 · Cited by 635
“However, SGLT1 is the primary pathway for glucose reabsorption in the intestine and is widely expressed throughout the body [25].”
BackgroundSelf-citationRenal, metabolic and cardiovascular considerations of SGLT2 inhibition
DeFronzo, R. A., Norton, L., & Abdul-Ghani, M. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.170 · Cited by 553
The tubular hypothesis of nephron filtration and diabetic kidney disease
Vallon, V., & Thomson, S. C. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0256-y · Cited by 465
Self-citationDevelopment of SGLT1 and SGLT2 inhibitors
Rieg, T., & Vallon, V. (2018) · Diabetologia · doi:10.1007/s00125-018-4654-7 · Cited by 377
Self-citationA more tubulocentric view of diabetic kidney disease
Zeni, L., Norden, A. G. W., Cancarini, G., & Unwin, R. J. (2017) · Journal of Nephrology · doi:10.1007/s40620-017-0423-9 · Cited by 255
Metadata
- Authors
- Song, P., Onishi, A., Koepsell, H., & Vallon, V.
- Venue
- Expert Opinion on Therapeutic Targets
- Publisher
- Informa UK Limited
- Published
- 2016-04-12
- Volume
- 20
- Issue
- 9
- Pages
- 1109-1125
- ISSN
- 1472-8222 (ISSN-L)
- 1744-7631
- OpenAlex
- W2309487596
- Cited by
- 194
- References
- 173
- FWCI
- 15.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.